{"name":"NeuroVia, Inc.","slug":"neurovia-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPazhGZ1pSVkxDNFVsYzFpcHhKdlFoM2ZzR0YzMjFhZWtzSVhEOWt0MG9BVnNEQjg0MllnbjFJbGpKNV9KQThkbW9zdzJkVVphT1gxa1hHWlA0NE1PWHNwNkxkRmx3M3NwajB3SXdoVkhVV0ZiWDc0TDA2b0lCSmMwOVdiU0REY1EtMk5zQ1VfY2dnNUk5aUlTYVNySC12R1l1SHZmSy1lOGRyb1JINWNB?oc=5","date":"2025-06-13","type":"pipeline","source":"BioSpace","summary":"Courage Therapeutics Appoints Biopharma Leader Giovanni Ferrara as CEO - BioSpace","headline":"Courage Therapeutics Appoints Biopharma Leader Giovanni Ferrara as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQcjhvNTh2MEt2SlVtcGlyN2gxam9MZkQwMml5TnpOeGFmcjhmcXNXMVlUZVZZUXVWUVgtaWNTemxpMU1uYlVrTENIWElEVGRKMTRnRG9BUWFUTG9XSzVsWVMtWXFjTjBFZF9CaXU5QmxaTG1lRnlZVDMzRlpVNjBSbjhoV0Y1bGxiOFYtZVVEajJzZkhLc1JfUW9aWQ?oc=5","date":"2020-09-24","type":"pipeline","source":"openPR.com","summary":"Adrenoleukodystrophy Drugs Market Growing at a CAGR of 15.9% - openPR.com","headline":"Adrenoleukodystrophy Drugs Market Growing at a CAGR of 15.9%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBuLVBkZjZQeWRNRGNQWFJHOFRQNWtBdWhZc2lVbGNQTDNDS0NTbmhVVWt2M0dLU0NWcWFQMEIzaGZCS241MzRnY29ZLVNvSnljdjdSWGNwc05UTVpoME5iVExsbnNSM0UyZzd4QkU4SGhkNDUzNDN5bF9ZU3o4QQ?oc=5","date":"2017-07-21","type":"pipeline","source":"globalventuring.com","summary":"NeuroVia journeys to $14m series A - globalventuring.com","headline":"NeuroVia journeys to $14m series A","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}